Merck & Co., Inc. (MRK)

Merck & Co. Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018
Research and Development	17.57B	17.94B	22.98B	20.43B	30.25B	30.53B	24.68B	25.77B
Research and Development Growth	-41.92%	-41.25%	-6.88%	-20.74%	98.37%	125.36%	92.19%	136.71%
Selling, General, and Administrative	10.89B	10.82B	10.76B	10.55B	10.51B	10.50B	10.39B	10.39B
Selling, General, and Administrative Growth	3.60%	2.98%	3.56%	1.51%	3.04%	4.60%	1.98%	3.87%
Restructuring	256.00M	310.00M	514.00M	584.00M	655.00M	599.00M	393.00M	361.00M
Restructuring Growth	-60.92%	-48.25%	30.79%	61.77%	-78.22%	-79.99%	-87.40%	-88.47%
Other Expenses	-29.00M	-27.00M	-75.00M	213.00M	343.00M	465.00M	312.00M	615.00M
Other Expenses Growth	-	-	-	-65.37%	-61.07%	-69.00%	-74.88%	69.42%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.